Trade Summary

3 days ago, Simon Barry J., serving as Dir at Immunitybio, Inc. (IBRX), sold 75,000 shares at $12.01 per share, for a total transaction value of $900,788.00. Following this transaction, Simon Barry J. now holds 2,850,821 shares of IBRX.

This sale represents a 3.00% decrease in Simon Barry J.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Immunitybio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.